Consortium partners

consortium-ppl 

Biomedical Research Foundation, Academy of Athens

Biomedical Research Foundation, Academy of Athens

Further Information : http://www.bioacademy.gr/

Organizational Activities

The Biomedical Research Foundation of the Academy of Athens (BRFAA) is one of the major Institutes for Biomedical research in Greece (featured in Nature, 2009, 458, p700-1). The BRFAA Proteomics Research Unit is equipped with multiple state-of the art proteomics technologies to be employed in NEURINOX, including systems for two-dimensional electrophoresis, liquid chromatography (HPLC, FPLC), preparative protein electrophoresis, spot pickers for automated spot excision, matrix assisted laser desorption-ionization time-of-flight mass spectrometer (MALDI-TOF/TOF) with imaging MS capabilities etc.

Role in the Project

Key Personnel

Antonia Vlahou, Ph.D is group leader and co-Director of the Proteomics Research Unit, BRFAA. With a Ph.D on cell biology from Baylor College of Medicine Houston USA, she has more than 10years experience on proteomics and has played leading role in the development of standardized approaches in biomarker discovery. Among her distinctions is the Pfizer Scholar in Urology award and her role as the Chair of the Management Committee of the European Kidney and Urine Proteomics COST Action (www.eurokup.org; 2008-2012). Dr Vlahou has also been partner in the FP7 DECanBIO (2008-2012) and is currently partner in Marie Curie IAPP ProtoClin. In NEURINOX she will coordinate the proteomics studies.

NEURINOX 

Manousos Makridakis Ph.D post-doctoral fellow, expertise in gel-based proteomics and mass spectrometry. Proteomics analysis of tissue samples and bioinformatics.

 NEURINOX

Panagiotis Zerefos Ph.D, post-doctoral fellow, Expertise in bioanalytical method development for proteomics and protein enrichment techniques. Proteomics analysis of plasma samples

 NEURINOX

Vassiliki Bitsika Ph.D post-doctoral fellow. Expertise in molecular biology and MALDI MS. Analysis of tissue samples by MALDI MS imaging.

 NEURINOX